Medications

Peresolimab found to be efficacious for rheumatoid arthritis

Peresolimab, a humanized immunoglobulin G1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway, is efficacious for patients with rheumatoid arthritis, according ...

Oncology & Cancer

T cells can activate themselves to fight tumors

When you need a bit of motivation, it often has to come from within. New research suggests cancer-fighting immune cells have found a way to do just that.

Immunology

Autoimmune disorders found to affect around 1 in 10 people

A new population-based study of 22 million people shows that autoimmune disorders now affect about 1 in 10 individuals. The work, published in The Lancet, also highlights important socioeconomic, seasonal, and regional differences ...

Diseases, Conditions, Syndromes

Researchers uncover new details on rare immune disease

In an 11-year study, researchers at the National Institutes of Health have further characterized idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune ...

page 9 from 40